Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Borrajo

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Nano Today|August 16, 2021
Antibody cooperative adsorption onto AuNPs and its exploitation to force natural killer cells to kill HIV-infected T cellsAntonio Astorga-Gamaza, Michele Vitali, Mireya L Borrajo, et al.
NPJ Vaccines|March 6, 2024
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA ConsortiumLaura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, et al.
NPJ Vaccines|May 18, 2024
Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA ConsortiumLaura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, et al.
Emerging Microbes & Infections|August 1, 2024
Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA ConsortiumLaura Marcos-Villar, Beatriz Perdiguero, María López-Bravo, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Nano Today|August 16, 2021
Antibody cooperative adsorption onto AuNPs and its exploitation to force natural killer cells to kill HIV-infected T cellsAntonio Astorga-Gamaza, Michele Vitali, Mireya L Borrajo, et al.
NPJ Vaccines|March 6, 2024
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA ConsortiumLaura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, et al.
NPJ Vaccines|May 18, 2024
Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA ConsortiumLaura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, et al.
Emerging Microbes & Infections|August 1, 2024
Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA ConsortiumLaura Marcos-Villar, Beatriz Perdiguero, María López-Bravo, et al.
Pageof 2